Exacerbation in Glycemic Control by Switching from Subcutaneous Dulaglutide Injection to Oral Semaglutide Administration in a Patient with Type 2 Diabetes, Who Had Undergone Gastrectomy
Year: 2024
Type: article
Study design: Case Report
Abstract: We describe a case of an 83-year-old man with type 2 diabetes, who had undergone laparoscopy-assisted pyloric 2/3 gastrectomy 7 years ago. Switch from subcutaneous injection of dulaglutide, a glucagon-like protein-1(GLP-1) receptor agonist (GLP-1RA), to administration of oral semaglutide, another GLP-1RA, exacerbated his glycemic status. Because semaglutide is absorbed from the stomach, administration of oral semaglutide to patients after gastrectomy should be avoided even if the surgery is a partial gastrectomy.
Institution: Dokkyo Medical University Saitama Medical Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7146589448
